National Bank of Canada’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
National Bank of Canada's ELV Position: Q2 2026 in Review
National Bank of Canada reduced its Elevance Health (ELV) stake by 48% in Q2 2026, selling an estimated $56.1M and leaving 161,584 shares worth $62.5M. The position accounts for 0.04% of the portfolio, ranked #306.
National Bank of Canada first reported a position in ELV in Q4 2021 and has held it in 19 quarters since. The position peaked at $92.5M in Q4 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- National Bank of Canada held 161,584 shares of Elevance Health worth $62.5M as of Q2 2026.
- National Bank of Canada sold 151,207 Elevance Health shares in Q2 2026, an estimated $56.1M.
- Elevance Health made up 0.04% of National Bank of Canada's portfolio in Q2 2026, its #306 holding.
- National Bank of Canada first reported a position in Elevance Health in Q4 2021 and has held it in 19 quarters since.
- National Bank of Canada's Elevance Health position peaked at $92.5M in Q4 2024.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.